Carcinoembryonic protein (carcinoembryonic antigen) of 195ng/ml in pancreatic cancer indicates that the tumor cells in the patient’s body are more active and the number of tumor cells is also higher. Carcinoembryonic antigen belongs to a kind of tumor marker in clinic, which can be used to assist in the diagnosis of cancer; the index of carcinoembryonic antigen in healthy people is lower than 5.0ng/ml, which is considered normal. After a patient suffers from cancer, with the growth and reproduction of tumor cells, the value of carcinoembryonic antigen in the patient’s body will increase. 195ng/ml of carcinoembryonic antigen in pancreatic cancer indicates that there is an obvious increase in the number of malignant tumor cells in the patient’s body, which is more active. Patients with pancreatic cancer usually have no obvious symptoms in the early stage, and some of them may suffer from indigestion or fullness and bloating, and with the development of the disease, they may suffer from epigastric pain, vomiting, vomiting of blood and other symptoms; patients should follow the principle of early detection and early treatment, and carry out the treatment in time, so as to avoid aggravation of the disease. Cardia cancer should go to hospital for systematic treatment in time to avoid aggravation of the condition.